Genomic Vision (GV)-Product Pipeline Analysis, 2017 Update

Genomic Vision (GV)-Product Pipeline Analysis, 2017 Update

  • Products Id :- GDME50847PD
  • |
  • Pages: 36
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Genomic Vision (Genomic) is a molecular diagnostics company that develops and commercializes diagnostic tests for genetic diseases and cancers. The company's portfolio comprises tests for breast cancer and colon cancer; diagnostic solution for facio-scapulo-humeral muscular dystrophy; and tools for identifying and characterizing rearrangements which affect the BRCA1 and BRCA2 genes. Its diagnostic tests are based on DNA molecular combing technology. Genomic's technology finds application in monitoring both spatial and temporal characteristics of DNA replication in a single experiment and identification of structural variations at any position within the genome. It conducts research studies on large genomic rearrangements and their involvement in cancer and genetic disorders to develop new assays for in vitro diagnostics and biomarker discovery. Genomic is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Genomic Vision

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Genomic Vision Company Overview 4

Genomic Vision Company Snapshot 4

Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4

Genomic Vision-Pipeline Analysis Overview 7

Genomic Vision-Key Facts 7

Genomic Vision-Major Products and Services 8

Genomic Vision Pipeline Products by Development Stage 9

Genomic Vision Ongoing Clinical Trials by Trial Status 11

Genomic Vision Pipeline Products Overview 13

BRCACombing Test 13

BRCACombing Test Product Overview 13

DNA Combing Based Test-Neurological Disorder 14

DNA Combing Based Test-Neurological Disorder Product Overview 14

FiberVision Automated Scanner 15

FiberVision Automated Scanner Product Overview 15

High-Throughput Scanner 16

High-Throughput Scanner Product Overview 16

HPV Combing Test 17

HPV Combing Test Product Overview 17

HPV Combing Test Clinical Trial 18

Lynch Syndrome Test 19

Lynch Syndrome Test Product Overview 19

Genomic Vision-Key Competitors 20

Genomic Vision-Key Employees 21

Genomic Vision-Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

Genomic Vision, Recent Developments 23

Jun 19, 2017: Genomic Vision Inks Chinese Distribution Deal with APG Bio 23

May 10, 2017: Genomic Vision Announces Promising Preliminary Results for Its Clinical Study in Cervical Cancer Detection in the Czech Republic 23

May 09, 2017: Genomic Vision: Financial Information at March 31, 2017 23

Mar 01, 2017: Genomic Vision: 2016 Annual Results 24

Jan 09, 2017: Genomic Vision Doubles Its Installed Base of FiberVision Platforms and Quadruples Its Sales of Products and Services in 2016 26

Jul 26, 2016: Genomic Vision Announces Results For The First Half Of 2016 27

Jul 20, 2016: Genomic Vision is accelerating its clinical trial in cervical cancer with an additional study in the Czech Republic 29

Jun 16, 2016: The Clinical Trial Undertaken by Genomic Vision and Reims University Hospital to Validate a New Test for the Early Detection and Treatment of Cervical Cancer Was Chosen for an Oral Presentation at the Eurogin Congress in Salzburg 29

Mar 23, 2016: Genomic Vision: New strategic development area 30

Mar 22, 2016: Genomic Vision: 2015 Annual Results 30

Appendix 33

Methodology 33

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Genomic Vision Pipeline Products by Equipment Type 5

Genomic Vision Pipeline Products by Development Stage 9

Genomic Vision Ongoing Clinical Trials by Trial Status 11

List of Tables

Genomic Vision Pipeline Products and Ongoing Clinical Trials Overview 4

Genomic Vision Pipeline Products by Equipment Type 5

Genomic Vision Pipeline Products by Indication 6

Genomic Vision Ongoing Clinical Trials by Trial Status 6

Genomic Vision, Key Facts 7

Genomic Vision, Major Products and Services 8

Genomic Vision Number of Pipeline Products by Development Stage 9

Genomic Vision Pipeline Products Summary by Development Stage 10

Genomic Vision Ongoing Clinical Trials by Trial Status 11

Genomic Vision Ongoing Clinical Trials Summary 12

BRCACombing Test-Product Status 13

BRCACombing Test-Product Description 13

DNA Combing Based Test-Neurological Disorder-Product Status 14

DNA Combing Based Test-Neurological Disorder-Product Description 14

FiberVision Automated Scanner-Product Status 15

FiberVision Automated Scanner-Product Description 15

High-Throughput Scanner-Product Status 16

High-Throughput Scanner-Product Description 16

HPV Combing Test-Product Status 17

HPV Combing Test-Product Description 17

HPV Combing Test-Association Between High-risk HPV Genome Integration Detected by Molecular Combing and Cervical Lesions Severity and/or Evolution 18

HPV Combing Test-Integration of Oncogenic HPV DNA in Czech Republic 18

Lynch Syndrome Test-Product Status 19

Lynch Syndrome Test-Product Description 19

Genomic Vision, Key Employees 21

Glossary 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Genomic Vision, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48668
Site License
USD 1500 INR 97335
Corporate User License
USD 2250 INR 146003



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]